Rutuja Sunil Naik

Mrs. Rutuja Sunil Naik

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MSMansaa Singh
Mansaa Singh
HAHasmiq Liba Arora
Hasmiq Liba Arora
RNRutuja Sunil Naik
Rutuja Sunil Naik
SJShravani Joshi
Shravani Joshi
KSKaveri Sonawane
Kaveri Sonawane
Birandra K. K SinhaBirandra K. K Sinha
Birandra K. K Sinha
Cancer drug resistance occurs when cancer cells evade cell death following treatment with chemotherapy, radiation therapy, and targeted therapies. This resistance is often linked to the reprogramming of programmed cell death (PCD) pathways, allowing cancer cells to survive drug-induced stress. However, certain anticancer therapies, when combined with specific agents or inhibitors, can induce ferroptosis—a form of cell death driven by iron-dependent lipid peroxidation. Currently, extensive preclinical and clinical research is underway to investigate the molecular, cellular, and tissue-specific mechanisms underlying ferroptosis, with the goal of identifying strategies to overcome drug resistance in cancers unresponsive to conventional PCD pathways. By harnessing ferroptosis, cancer cells can be compelled to undergo lipid peroxidation-induced death, potentially improving therapeutic outcomes in patients with cancer. This short review aims to enhance the understanding of ferroptosis inducers in cancer therapy and stimulate further research into ferroptosis-based approaches for more effective clinical cancer treatment.

25 October 2024
Verified
Conference Paper
Closed access
DBDhanashree Bomle
Dhanashree Bomle
RNRutuja Sunil Naik
Rutuja Sunil Naik
ASAtharva Shinde
Atharva Shinde
VPVaidehi Patel
Vaidehi Patel
KKKratika Khunteta
Kratika Khunteta
NSNilesh Kumar Sharma
Nilesh Kumar Sharma
In India and around the world, the rates at which metabolic disorders like diabetes and cancer are becoming more prevalent are concerning. For the purpose of improving economical burdens and better managing metabolic disorders like diabetes and cancer, early detection of these diseases is essential. In recent, artificial intelligence and machine learning tools have provided impetus to the rapid and accurate early diagnosis of diseases like diabetes and cancer. Also, noninvasive and discarded tissues are preferred over invasive and surgical approaches for the diagnosis of diseases. The present invention describes the Nail Impression Technique (NIT) providing a painless, and needle-free method for diagnosing various illnesses. This invention requires a nail impression of the patient, which is collected by an in-house nail impression-capturing tool and analyzed by a computer-assisted imaging tool to generate unique graphs and histograms for healthy and clinical subjects. For the accurate prediction of diseases, a machine learning tool is employed. This invention is an environmentally compatible technique, generating only biodegradable waste, such as paper, and eliminating biological waste generated by traditional diagnostic methods.